window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-ZXTT8H6EZ1');

iThera Medical reports initiation of fifth clinical site in EUPHORIA study for the non-invasive assessment of IBD

By |2022-06-22T08:41:19+01:00June 22nd, 2022|

Medical device company iThera Medical, our coordinator, announces that the fifth site has been initiated for the ongoing clinical study in the EUPHORIA project that aims to further develop the company’s proprietary optoacoustic imaging technology and demonstrate its clinical value in the assessment of inflammatory bowel disease (IBD). The EUPHORIA (Enhancing Ultrasound and PHOtoacoustics for [...]

Coordinator iThera Medical leads €1.6m project to develop machine learning-assisted optoacoustic imaging of neuromuscular disease

By |2022-05-17T20:48:34+01:00May 17th, 2022|

Congratulations to our coordinators iThera Medical who announced the kickoff of the technology innovation project SMART-3D funded by the Bavarian Research Foundation, www.forschungsstiftung.de. Commencing on May 1st, 2022, the new project aims to develop a novel, innovative approach to monitoring neuromuscular disease in pediatric patients through the company’s proprietary optoacoustic imaging technology and next-generation 3D image [...]

Partner News: iThera Medical introduces the world’s first transmission ultrasound system

By |2021-10-07T15:03:20+01:00October 7th, 2021|

Today, EUPHORIA Coordinators iThera Medical announced the launch of its new inVision TRIO preclinical optoacoustic imaging system. The inVision TRIO is the first imaging system in the world that incorporates transmission ultrasound computed tomography (TUCT) and expands the field of biomedical applications addressable using iThera Medical’s optoacoustic imaging systems. The new inVision TRIO offers tremendous flexibility [...]

iThera leads €1.9m research project to advance optoacoustic imaging technology towards AI-supported quantitative medical diagnosis

By |2021-09-13T15:12:27+01:00September 13th, 2021|

EUPHORIA Coordinators, iThera Medical GmbH has received grant funding from the Bavarian Ministry of Economic Affairs, Regional Development and Energy to conduct a Euro 1.9 million R&D project to develop next-generation AI-supported electronics for its MSOT imaging systems for inflammatory bowel disease. The Bavarian state-funded technology innovation project, DeepOPUS, launched today, September 13th, 2021, aims to augment [...]

EUPHORIA CE mark announcement featured by CORDIS

By |2021-07-01T09:45:24+01:00July 1st, 2021|

The Community Research and Development Information Service (CORDIS), the European Commission's primary source of results from the projects funded by the EU's framework programmes for research and innovation featured EUPHORIA news on June 23rd, 2021. The mission of CORDIS is to bring research results to professionals in the field to foster open science, create innovative [...]

CE mark awarded to iThera Medical’s MSOT Acuity Echo – a major project milestone

By |2021-06-10T08:14:14+01:00June 9th, 2021|

"We are very excited about the CE certification of our MSOT Acuity Echo system. The integration of ultrasound imaging is key for clinical users of optoacoustics" said Christian Wiest, CEO and co-founder of iThera Medical. Dr Philipp Bell, Chief Commercial Officer at iThera and Coordinator of EUPHORIA said "Obtaining the CE mark is a major milestone for [...]

PRESS RELEASE: Approval for EUPHORIA’s pivotal clinical trial to assess colon inflammation in patients with inflammatory bowel disease

By |2020-10-29T12:25:03+00:00October 20th, 2020|

Munich, DE – Medical device company iThera Medical announces regulatory approval for a pivotal multi-center trial in patients with inflammatory bowel disease (IBD). The  EUPHORIA (Enhancing Ultrasound & Photoacoustics for Recognition of Intestinal Abnormalities) clinical trial will commence at four investigational sites across Germany and Italy using iThera Medical’s proprietary optoacoustic imaging technology, MSOT (multispectral [...]

EUPHORIA-acknowledged paper published in Nature Medicine, 2 December 2019

By |2019-12-02T17:00:39+00:00December 2nd, 2019|

Congratulations to EUPHORIA PIs Dr. Ferdinand Knieling and Dr. med. Maximilian J. Waldner and the team consisting of Adrian Regensburger, Lina M. Fonteyne, Jörg Jüngert,  Alexandra L. Wagner, Teresa Gerhalter, Armin M. Nagel, Rafael Heiss, Florian Flenkenthaler, Matthias Qurashi, Markus F. Neurath, Nikolai Klymiuk, Elisabeth Kemter, Thomas Fröhlich, Michael Uder, Joachim Woelfle, Wolfgang Rascher, Regina [...]

EUPHORIA PI Dr Ferdinand Knieling takes the 2019 Adalbert Czerny Award

By |2019-09-23T13:36:28+01:00September 24th, 2019|

Dr Ferdinand Knieling from the University Hospital Erlangen was awarded the Adalbert Czerny Award 2019 from the German Society for Pediatrics and Youth Medicine for his work on innovative diagnostic methods. Ferdinand was the first to apply a newly developed multispectral optoacoustic (MSOT) imaging method, which non-invasively provides information about tissue composition, on patients with [...]

iThera Medical Announces Strategic Partnership to Enhance in vivo Imaging Capabilities with the MSOT

By |2019-05-01T12:31:07+01:00May 1st, 2019|

On 30 April 2019,  iThera Medical GmbH and Invicro LLC, a Konica Minolta company, announced a unique partnership with the placement of the MSOT inVision platform in Invicro's in vivo laboratory at its headquarters in Boston, USA. The companies will come together to uniquely offer pharmaceutical, biotechnology and academic sponsors services from the optoacoustic platform [...]

Go to Top